SFM
ATNM icon

Sphera Funds Management’s Actinium Pharmaceuticals ATNM Stock Holding History

Sphera Funds Management’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-9,710
Closed -$1.95M – 131
2014
Q3 		$1.95M Sell
9,710
-290
-3% -$57.5K 0.24% 86
2014
Q2 		$2.17M Buy
+10,000
New +$3.33M 0.53% 46

Other funds holding ATNM

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return

Sphera Funds Management's ATNM Position: Q4 2014 in Review

Sphera Funds Management sold out of Actinium Pharmaceuticals (ATNM) in Q4 2014, closing a stake of 9,710 shares — an estimated $1.95M sold.

Sphera Funds Management first reported a position in ATNM in Q2 2014 and held it in 2 quarters. The position peaked at $2.17M in Q2 2014. 36 funds tracked by Wall St. Rank hold ATNM as of Q4 2014.

  • Sphera Funds Management reported no remaining Actinium Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Sphera Funds Management sold 9,710 Actinium Pharmaceuticals shares in Q4 2014, an estimated $1.95M.
  • Sphera Funds Management first reported a position in Actinium Pharmaceuticals in Q2 2014 and held it in 2 quarters.
  • Sphera Funds Management's Actinium Pharmaceuticals position peaked at $2.17M in Q2 2014.
  • 36 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q4 2014.

Based on Sphera Funds Management's 13F filing for Q4 2014, filed 12 Feb 2015.